SERPINA1 and Wilson disease: Other studies on the development of HCC have shown that it leads to changes in hemochromatosis, α1‐antitrypsin deficiency (SERPINA1), glycogen storage disease (G6PC, SLC37A4), tyrosinemia (FAH), porphyria (HMBS, UROD), and Wilson disease (ATP7B).